Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP254414.RAaLPXkCyEiZVUDC5Uz7S9xwngnmif36cbqfz1Np5RVNo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP254414.RAaLPXkCyEiZVUDC5Uz7S9xwngnmif36cbqfz1Np5RVNo130_assertion type Assertion NP254414.RAaLPXkCyEiZVUDC5Uz7S9xwngnmif36cbqfz1Np5RVNo130_head.
- NP254414.RAaLPXkCyEiZVUDC5Uz7S9xwngnmif36cbqfz1Np5RVNo130_assertion description "[Most RA sera bound to recombinant amino-terminal region and domain I but not to domain L. This prompted us to use a recombinant polypeptide corresponding to the domain I of calpastatin as the antigen in a solid-phase ELISA to test sera from patients with various systemic rheumatic diseases and healthy controls.Anti-calpastatin domain I antibodies (ACAST-DI Ab), were detected by ELISA in RA, systemic lupus erythematosus (SLE), Sj�gren's syndrome and control sera at respective frequencies of 10, 9, 0 and 1%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254414.RAaLPXkCyEiZVUDC5Uz7S9xwngnmif36cbqfz1Np5RVNo130_provenance.
- NP254414.RAaLPXkCyEiZVUDC5Uz7S9xwngnmif36cbqfz1Np5RVNo130_assertion evidence source_evidence_literature NP254414.RAaLPXkCyEiZVUDC5Uz7S9xwngnmif36cbqfz1Np5RVNo130_provenance.
- NP254414.RAaLPXkCyEiZVUDC5Uz7S9xwngnmif36cbqfz1Np5RVNo130_assertion SIO_000772 12367559 NP254414.RAaLPXkCyEiZVUDC5Uz7S9xwngnmif36cbqfz1Np5RVNo130_provenance.
- NP254414.RAaLPXkCyEiZVUDC5Uz7S9xwngnmif36cbqfz1Np5RVNo130_assertion wasDerivedFrom befree-20140225 NP254414.RAaLPXkCyEiZVUDC5Uz7S9xwngnmif36cbqfz1Np5RVNo130_provenance.
- NP254414.RAaLPXkCyEiZVUDC5Uz7S9xwngnmif36cbqfz1Np5RVNo130_assertion wasGeneratedBy ECO_0000203 NP254414.RAaLPXkCyEiZVUDC5Uz7S9xwngnmif36cbqfz1Np5RVNo130_provenance.